Biomomentum多軸機械測試儀Mach-1應用：立體光刻3D生物打印方法制作人角膜基質等效物。

生物醫學工程學年鑒，生物材料-工程細胞行為，已出版：2020年6月5日3D生物打印技術是用于角膜基質組織再生的一種有前途的方法。在這項研究中，與角膜基質細胞混合的甲基丙烯酸明膠（GelMA）被用作生物墨水。基于可見光的立體光刻（SLA）3D生物打印方法用于打印人類角膜基質的解剖學相似的圓頂形結構。測試了兩種不同濃度的GelMA大分子單體（7.5和12.5％）的角膜基質生物印記。由于高聚物濃度高，12.5％的GelMA比7.5％的GelMA堅硬，這使其更易于處理。就生物印刷支架的水含量和透光率而言，我們觀察到具有12.5％GelMA濃度的支架更接近于天然角膜基質組織。回到頂端|提供反饋信息的人隨后，細胞增殖，研究了在生物打印支架中封裝的人角膜基質細胞的基因和蛋白質表達。在第1天和第7天，觀察到在12.5％GelMA支架中的細胞相容性分別為81.86和156.11％，顯著高于7.5％GelMA支架中的細胞相容性。7天后在12.5％的GelMA樣品中觀察到角膜基質細胞伸長，表明細胞附著，生長和在支架內的整合。與在塑料組織培養板上培養的細胞相比，在12.5％GelMA支架中培養的細胞的I型膠原蛋白，盧米肯和硫酸角質素的基因表達隨時間增加。28天后，還使用免疫組織化學法觀察了I型膠原蛋白和lumican的表達。使用垂直軸的微機械測試儀（測定交聯時間MACH-c，Biomomentum，加拿大）。

Abstract

3D bioprinting technology is a promising approach for corneal stromal tissue regeneration. In this study, gelatin methacrylate (GelMA) mixed with corneal stromal cells was used as a bioink. The visible light-based stereolithography (SLA) 3D bioprinting method was utilized to print the anatomically similar dome-shaped structure of the human corneal stroma. Two different concentrations of GelMA macromer (7.5 and 12.5%) were tested for corneal stroma bioprinting. Due to high macromer concentrations, 12.5% GelMA was stiffer than 7.5% GelMA, which made it easier to handle. In terms of water content and optical transmittance of the bioprinted scaffolds, we observed that scaffold with 12.5% GelMA concentration was closer to the native corneal stroma tissue. Subsequently, cell proliferation, gene and protein expression of human corneal stromal cells encapsulated in the bioprinted scaffolds were investigated. Cytocompatibility in 12.5% GelMA scaffolds was observed to be 81.86 and 156.11% at day 1 and 7, respectively, which were significantly higher than those in 7.5% GelMA scaffolds. Elongated corneal stromal cells were observed in 12.5% GelMA samples after 7 days, indicating the cell attachment, growth, and integration within the scaffold. The gene expression of collagen type I, lumican and keratan sulfate increased over time for the cells cultured in 12.5% GelMA scaffolds as compared to those cultured on the plastic tissue culture plate. The expression of collagen type I and lumican were also visualized using immunohistochemistry after 28 days. These findings imply that the SLA 3D bioprinting method with GelMA hydrogel bioinks is a promising approach for corneal stroma tissue biofabrication.

The crosslinking time was determined using a vertical axis micromechanical tester (Mach-1 v500c, Biomomentum Inc., Montreal, QC, Canada) by recording in situ gelation kinetics.